Cargando…
Long-term Outcomes from Proton Therapy for Sinonasal Cancers
PURPOSE: To report long-term disease control, survival, and toxicity after proton therapy for sinonasal cancer. PATIENTS AND METHODS: We reviewed 143 cases of adults with nonmetastatic sinonasal cancers treated with primary (18%; n = 26) or adjuvant (82%; n = 117) proton therapy. The most common his...
Autores principales: | Dagan, Roi, Uezono, Haruka, Bryant, Curtis, Holtzman, Adam L., Morris, Christopher G., Mendenhall, William M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Particle Therapy Co-operative Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270098/ https://www.ncbi.nlm.nih.gov/pubmed/34285947 http://dx.doi.org/10.14338/IJPT-20-00068.1 |
Ejemplares similares
-
Passively Scattered Proton Therapy for Nonmelanoma Skin Cancer with Clinical Perineural Invasion
por: Bryant, Curtis M., et al.
Publicado: (2021) -
Clinical Outcomes Following Dose-Escalated Proton Therapy for Skull-Base Chordoma
por: Holtzman, Adam L., et al.
Publicado: (2021) -
CBCT-Based Dose Monitoring and Adaptive Planning Triggers in Head and Neck PBS Proton Therapy
por: Reiners, Keaton, et al.
Publicado: (2023) -
Spot Scanning Proton Therapy for Sinonasal Malignant Tumors
por: Nakajima, Koichiro, et al.
Publicado: (2021) -
Insurance Approval for Definitive Proton Therapy for Prostate Cancer
por: Mendenhall, William M., et al.
Publicado: (2021)